We contribute to the development of novel treatments by: 1. Peptide-based drug discovery combining advantages of small molecules and high molecular weight biologics. Our proprietary cDNA peptide display is a powerful technique for construction and screening of a very large (10 trillion) peptide libraries with variety of structures (cyclic, low molecular weight antibodies, scaffold, order-made design), functional or affinity selection to cell surface or intracellular targets. 2. Manufacture of high performance Mesenchymal Stem Cells (MSC) according to specific properties for clinical use. Our state-of-the art clinical level cell processing facility is certified by the Japanese Ministry of Health, Labour and Welfare. 3. Collaborative development of therapeutic products for specific indications, using peptide-based drugs or Mesenchymal Stem Cells. Our panel of experts is ready to work with you for the development of clinical solutions for challenging diseases.